Acts as an interferon antagonist when expressed ex vivo. SARS-CoV-2 ORF3b is homologous to SARS-CoV ORF3b, although the proposed protein is much shorter due to the presence of premature stop codons (Probable). Elicits strong specific antibody response (PubMed:32807944). Product of a dubious CDS prediction.